Valuation
- Market cap
- 22,907,000
- Revenue TTM
- $1,140,000
- Net income TTM
- $-19,880,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -1,743.86%
- Debt to equity
- 0.00
Trading
- Volume
- 737,400
- Avg volume
- 3,385,894
- Day's range
- $1.31 – $1.47
- Shares out
- 15,690,000
- Stochastic %K
- 23%
- Beta
- 0.51
- Analysts
- Strong Buy
- Price target
- —
Company profile
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which...
Show more
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
- Industry
- Software - Application
- Sector
- Technology
- Phone
- 888 237 6412
- Website
- https://fireflyneuro.com
- Address
- 1100 Military Road, Kenmore, United States
Latest news
No headlines yet.
